Previous close | 48.10 |
Open | 48.10 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 50.00 |
Expiry date | 2026-01-16 |
Day's range | 48.10 - 48.10 |
Contract range | N/A |
Volume | |
Open interest | N/A |
MUMBAI, India, May 06, 2024--KKR, a leading global investment firm, today announced the signing of definitive agreements under which funds managed by KKR will acquire Healthium Medtech Ltd. ("Healthium"), a leading Indian medical devices company, from an affiliate of Funds advised by Apax Partners LLP ("Apax"), a leading global private equity advisory firm. The acquisition will be made by a special purpose vehicle owned by KKR-managed funds which will acquire a controlling interest in Healthium
KKR ( NYSE:KKR ) First Quarter 2024 Results Key Financial Results Revenue: US$10.6b (up 231% from 1Q 2023). Net income...
Discover how KKR & Co Inc achieved significant earnings growth and strategic advancements in the first quarter of 2024.